MedPath

SER-AP-ES TAB

SER-AP-ES TAB

Discontinued
DIN Number

00074608

Drug Class

Human

Market Date

Dec 31, 1960

Company
HC

novartis pharmaceuticals canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00074608
AIG Number0301058001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02LA01 RESERPINE AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:08.32
Health Canada Classification

ACTIVE INGREDIENTS (3)

HYDRALAZINE HYDROCHLORIDEActive
Strength: 25 MG
Monograph: HYDRALAZINE HYDROCHLORIDE
HYDROCHLOROTHIAZIDEActive
Strength: 15 MG
Monograph: HYDROCHLOROTHIAZIDE
RESERPINEActive
Strength: 0.1 MG
Monograph: RESERPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.